RFCL Limited, an ICICI Venture company, announces its first global acquisition in the space of veterinary healthcare through a share purchase agreement with Marsing & Co Limited A/S for its Germany based subsidiary co. Bremer Pharma GmbH. The agreement is for transfer of all key people, assets, brands and the name "Bremer Pharma", all contracts including exports. RFCL will gain a marketing foothold in Bremerhaven, near Hamburg and a state-of-the-art manufacturing base in Warburg-Scherfede.6:26 PM on March 31
Be the first to comment...
Add Your Comment